Patent assignee · NL · COMPANY

GENMAB B.V.

13Patents
13Active
13Granted
48Portfolio score

Filing activity: Jul 6, 2012 → Jul 22, 2021

Most-cited patents

PatentTitleAreaCited byStatus
US11180572B2 Dimeric protein with triple mutations Chemistry; Metallurgy 9 Active
US10759867B2 Antibody variants and uses thereof Chemistry; Metallurgy 9 Active
US11512137B2 Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Physics 5 Active
US11396553B2 Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Physics 4 Active
US12049512B2 Antibody variants and uses thereof Chemistry; Metallurgy 3 Active
US11034772B2 Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Physics 3 Active
US10882913B2 Anti-DR5 antibodies and methods of use thereof Chemistry; Metallurgy 3 Active
US12173076B2 Polypeptide variants and uses thereof Chemistry; Metallurgy 1 Active
US12247080B2 Anti-DR5 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US9611327B2 Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US12275797B2 Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof Chemistry; Metallurgy 0 Active
US12338289B2 Antibody variant combinations and uses thereof Chemistry; Metallurgy 0 Active
US10647774B2 Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.